Stanford Cancer Institute Directory
Population Sciences Profiles
Showing 21 - 30 of 30
Professor of Pathology and of Genetics
Please refer to my NIH biosketch: http://mendel.stanford.edu/sidowlab/SidowCurrentBiosketch.pdf
Stanford W. Ascherman, MD, FACS, Professor in Genetics
1977 B.A, Chemistry and Biology, University of Rochester, NY 1978-1982 Ph.D. California Institute of Technology, CA Advisor: Dr. Norman Davidson 1982-1986 Postdoctoral Research Stanford University School of Medicine, CA Advisor: Dr. Ronald Davis 1986-2009 Faculty Dept of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT 2009-present Dept of Genetics, Stanford University School of Medicine, Stanford, CA
Lui Hac Minh Professor in the School of Medicine
Dr. Samuel So is the Lui Hac Minh Professor and Professor of Surgery. He is also the founder of the multidisciplinary liver cancer program at the Stanford Cancer Center, and the founder and executive director of the Asian Liver Center at Stanford University School of Medicine. Dr. So is a native of Hong Kong and received his surgical training at the University of Hong Kong and the University of Minnesota where he also completed his fellowship in multi-organ transplantation. His current clinical area of specialty is multidisciplinary approach in the treatment of primary liver cancer and management of chronic hepatitis B infection. He is listed among the Best Doctors in America. Dr. So is recognized worldwide for his expertise in chronic hepatitis B and primary liver cancer prevention, research, treatment and health policy. He served as a consultant for the FDA and was a member and co-chair of the U.S. Department of Health and Human Services Office of Minority Health’s Hepatitis B Expert Panel. He was also a member of the Board of Population Health and Public Health Practices of the Institute of Medicine of the National Academies, and a committee member of the 2010 IOM report on “Hepatitis and Liver Cancer: a national strategy for the prevention and control of hepatitis B and C”, and the 2016 National Academy of Sciences, Engineering and Medicine report on “Eliminating the Public Health Problem of Hepatitis B and C in the United States. He also serves as a special adviser on viral hepatitis for the World Health Organization Western Pacific regional office. In 2010, he received the CDC and ATSDR Honor Award for mobilizing people and resources in ways that have changed global public health policies related to hepatitis B, and was recognized in 2014 by the White House for global and national leadership in the prevention and control of viral hepatitis.
Jack, Samuel and Lulu Willson Professor in Medicine
Dr. David Spiegel is Willson Professor and Associate Chair of Psychiatry & Behavioral Sciences, Director of the Center on Stress and Health, and Medical Director of the Center for Integrative Medicine at Stanford University School of Medicine, where he has been a member of the academic faculty since 1975, and was Chair of the Faculty Senate from 2010-2011. Dr. Spiegel has 40 years of clinical and research experience studying psycho-oncology, stress and health, pain control, psychoneuroendocrinology, sleep, hypnosis, and conducting randomized clinical trials involving psychotherapy for cancer patients. He has published twelve books, 383 scientific journal articles, and 167 book chapters on hypnosis, psychosocial oncology, stress physiology, trauma, and psychotherapy. His research has been supported by the National Institute of Mental Health, the National Cancer Institute, the National Institute on Aging, the National Center for Complementary and Integrative Health, the John D. and Catherine T. MacArthur Foundation, the Fetzer Institute, the Dana Foundation for Brain Sciences, and the Nathan S. Cummings Foundation. He was a member of the work groups on stressor and trauma-related disorders for the DSM-IV and DSM-5. He is Past President of the American College of Psychiatrists and the Society for Clinical and Experimental Hypnosis, and is a Member of the National Academy of Medicine.
Professor (Research) of Medicine (Stanford Prevention Research Center), of Obstetrics and Gynecology and, by courtesy, of Health Research and Policy (Epidemiology)
Professor of Dermatology at Palo Alto Veterans Affairs Health Care System and the Stanford University Medical Center
Susan M. Swetter, M.D., is a Professor of Dermatology, Assistant Chief of the Dermatology Service at the VA Palo Alto, and Director of the Pigmented Lesion and Melanoma Program at Stanford University Medical Center and Cancer Institute. She also serves as Physician Leader of the Cancer Care Program in Cutaneous Oncology at Stanford. Dr. Swetter's research interests encompass both primary and secondary melanoma prevention, including therapeutic prevention strategies in patients with atypical nevi and targeted screening/education of high-risk groups for improved melanoma awareness and early detection. Her clinical interests are in cutaneous oncology/melanoma (at both Stanford and VA Palo Alto) and adult general medical dermatology (at VA Palo Alto).